Champlain Investment Partners LLC lowered its position in Actuant (NYSE:ATU) by 3.5% during the first quarter, HoldingsChannel reports. The firm owned 1,975,305 shares of the industrial products company’s stock after selling 71,860 shares during the period. Champlain Investment Partners LLC’s holdings in Actuant were worth $45,926,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently made changes to their positions in the business. Principal Financial Group Inc. lifted its holdings in Actuant by 2.8% in the 1st quarter. Principal Financial Group Inc. now owns 459,952 shares of the industrial products company’s stock valued at $10,694,000 after purchasing an additional 12,318 shares in the last quarter. Cooke & Bieler LP raised its holdings in shares of Actuant by 4.4% during the 1st quarter. Cooke & Bieler LP now owns 709,630 shares of the industrial products company’s stock worth $16,499,000 after acquiring an additional 30,220 shares during the period. Sei Investments Co. raised its holdings in shares of Actuant by 493.6% during the 1st quarter. Sei Investments Co. now owns 70,789 shares of the industrial products company’s stock worth $1,646,000 after acquiring an additional 58,864 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Actuant by 9.0% during the 1st quarter. JPMorgan Chase & Co. now owns 573,887 shares of the industrial products company’s stock worth $13,342,000 after acquiring an additional 47,212 shares during the period. Finally, Oppenheimer Asset Management Inc. raised its holdings in shares of Actuant by 45.4% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 24,335 shares of the industrial products company’s stock worth $566,000 after acquiring an additional 7,602 shares during the period.
Top 10 Value Stocks For 2019: MoSys, Inc.(MOSY)
Advisors' Opinion:- [By Lisa Levin]
MoSys, Inc. (NASDAQ: MOSY) shares were also up, gaining 21 percent to $1.84 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
- [By Lisa Levin] Gainers Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading. Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut. Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading. Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading. Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading. MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading. Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan. Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading. MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading. Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results. Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading. Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings. Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.
- [By Lisa Levin] Gainers The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance. WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results. MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast. Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39. Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval. Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results. ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings. Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million. Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results. Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results. VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71. Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results. Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results. Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results. Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739. Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
- [By Lisa Levin]
MoSys, Inc. (NASDAQ: MOSY) shares were also up, gaining 27 percent to $1.9265 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
- [By Stephan Byrd]
MoSys Inc. (NASDAQ:MOSY)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $0.49, but opened at $0.58. MoSys shares last traded at $0.26, with a volume of 36053 shares changing hands.
Top 10 Value Stocks For 2019: Ultra Petroleum Corp.(UPL)
Advisors' Opinion:- [By Max Byerly]
Ultra Petroleum Corp (NASDAQ:UPL) – Research analysts at Capital One Financial dropped their FY2018 earnings per share estimates for shares of Ultra Petroleum in a report issued on Tuesday, September 18th. Capital One Financial analyst B. Velie now forecasts that the company will earn $0.71 per share for the year, down from their previous estimate of $0.81. Capital One Financial currently has a “Underweight” rating on the stock. Capital One Financial also issued estimates for Ultra Petroleum’s FY2019 earnings at $0.40 EPS.
- [By Logan Wallace]
Ultra Petroleum Corp (NASDAQ:UPL) shares dropped 3.3% during mid-day trading on Wednesday . The stock traded as low as $2.12 and last traded at $2.03. Approximately 135,000 shares were traded during mid-day trading, a decline of 97% from the average daily volume of 4,832,663 shares. The stock had previously closed at $2.10.
- [By Matthew DiLallo]
Shares of Ultra Petroleum Corp (NASDAQ:UPL) were down more than 12% on Friday at 2:30 p.m. EDT. That's due to continued selling pressure after the company reported first-quarter results yesterday where it detailed a risky go-forward plan. That move caused shares to plunge yesterday, and are now down 28% over the past two days.
Top 10 Value Stocks For 2019: RealPage, Inc.(RP)
Advisors' Opinion:- [By Logan Wallace]
Rothschild Asset Management Inc. decreased its stake in RealPage Inc (NASDAQ:RP) by 14.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 760,947 shares of the software maker’s stock after selling 126,009 shares during the period. Rothschild Asset Management Inc.’s holdings in RealPage were worth $41,928,000 at the end of the most recent quarter.
- [By Shane Hupp]
BidaskClub upgraded shares of RealPage (NASDAQ:RP) from a buy rating to a strong-buy rating in a research note published on Wednesday.
A number of other equities research analysts have also issued reports on RP. JPMorgan Chase & Co. assumed coverage on shares of RealPage in a report on Thursday, June 21st. They issued an overweight rating and a $76.00 price objective for the company. Zacks Investment Research raised shares of RealPage from a hold rating to a buy rating and set a $69.00 target price on the stock in a research report on Thursday, May 10th. KeyCorp upped their target price on shares of RealPage from $65.00 to $67.00 and gave the company an overweight rating in a research report on Friday, August 3rd. Finally, Royal Bank of Canada upped their target price on shares of RealPage to $64.00 and gave the company a sector perform rating in a research report on Friday, August 3rd. Two investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of Buy and a consensus target price of $63.88.
- [By Joseph Griffin]
RealPage Inc (NASDAQ:RP) Chairman Stephen T. Winn sold 794,939 shares of the stock in a transaction dated Friday, June 22nd. The stock was sold at an average price of $56.73, for a total transaction of $45,096,889.47. Following the completion of the transaction, the chairman now directly owns 1,674,645 shares of the company’s stock, valued at $95,002,610.85. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Top 10 Value Stocks For 2019: NVE Corporation(NVEC)
Advisors' Opinion:- [By Motley Fool Transcribing]
NVE (NASDAQ:NVEC) Q1 2019 Earnings Conference CallJul. 18, 2018 4:00 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Ethan Ryder]
NVE (NASDAQ:NVEC) was downgraded by ValuEngine from a “buy” rating to a “hold” rating in a research note issued to investors on Monday.
- [By Joseph Griffin]
Kayne Anderson Rudnick Investment Management LLC increased its holdings in NVE Co. (NASDAQ:NVEC) by 1.3% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 741,605 shares of the semiconductor company’s stock after purchasing an additional 9,645 shares during the period. Kayne Anderson Rudnick Investment Management LLC owned approximately 15.32% of NVE worth $61,635,000 at the end of the most recent quarter.
- [By Stephan Byrd]
NVE Co. (NASDAQ:NVEC) shares hit a new 52-week high and low on Wednesday . The stock traded as low as $105.88 and last traded at $103.80, with a volume of 52 shares changing hands. The stock had previously closed at $104.57.
Top 10 Value Stocks For 2019: GAIN Capital Holdings, Inc.(GCAP)
Advisors' Opinion:- [By Joseph Griffin]
These are some of the news articles that may have impacted Accern’s scoring:
Get GAIN Capital alerts: eToro Announces U.S. Crypto Trading (finance.yahoo.com) Strength: Opportunity zones should spur new growth (savannahnow.com) How Has the New US Tax Law Affected Deductions for Foreign Property Ownership? (mansionglobal.com) How to properly give the cottage to your kids (theglobeandmail.com) GAIN Capital (GCAP) Presents At Needham Emerging Technology Conference – Slideshow (seekingalpha.com)GAIN Capital opened at $8.15 on Wednesday, MarketBeat Ratings reports. GAIN Capital has a fifty-two week low of $5.63 and a fifty-two week high of $13.26. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 0.44. The stock has a market cap of $364.74 million, a PE ratio of -40.75, a price-to-earnings-growth ratio of 1.43 and a beta of 0.01.
- [By Stephan Byrd]
Gain Capital Holdings Inc (NYSE:GCAP) Director Alex Goor purchased 17,434 shares of the business’s stock in a transaction dated Friday, July 27th. The shares were bought at an average price of $7.50 per share, with a total value of $130,755.00. Following the purchase, the director now directly owns 85,980 shares of the company’s stock, valued at $644,850. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
- [By Joseph Griffin]
GAIN Capital (NYSE:GCAP) General Counsel Diego Rotsztain sold 3,184 shares of the company’s stock in a transaction on Monday, May 7th. The shares were sold at an average price of $8.23, for a total value of $26,204.32. Following the completion of the transaction, the general counsel now directly owns 98,663 shares in the company, valued at approximately $811,996.49. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
- [By Ethan Ryder]
LSV Asset Management decreased its position in GAIN Capital (NYSE:GCAP) by 3.1% in the 1st quarter, HoldingsChannel reports. The fund owned 410,684 shares of the financial services provider’s stock after selling 13,200 shares during the period. LSV Asset Management’s holdings in GAIN Capital were worth $2,772,000 as of its most recent filing with the Securities & Exchange Commission.
- [By Shane Hupp]
These are some of the media stories that may have impacted Accern’s scoring:
Get Gain Capital alerts: Gain Capital Holdings Inc (GCAP) Given Average Rating of “Buy” by Brokerages (americanbankingnews.com) Have a grip on these : Harmonic Inc. (NASDAQ:HLIT), GAIN Capital Holdings, Inc. (NYSE:GCAP), Mitcham Industries … (journalfinance.net) Stocks Trending Alert- Ceragon Networks Ltd. (NASDAQ:CRNT), GAIN Capital Holdings, Inc. (NYSE:GCAP), Wheeler … (journalfinance.net) Exclusive: FOREX.com Head of Research James Chen jumps to Investopedia (leaprate.com) GAIN Capital’s GetGo app bolsters Performance tab functionalities (financefeeds.com)Gain Capital opened at $8.19 on Thursday, MarketBeat Ratings reports. The stock has a market capitalization of $369.22 million, a price-to-earnings ratio of -40.95, a PEG ratio of 1.45 and a beta of -0.01. Gain Capital has a 12 month low of $5.66 and a 12 month high of $13.26. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 0.44.
Top 10 Value Stocks For 2019: Fifth Street Asset Management Inc.(FSAM)
Advisors' Opinion:- [By Logan Wallace]
Fifth Street Asset Management (OTCMKTS:FSAM) and U.S. Global Investors (NASDAQ:GROW) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, institutional ownership, profitability, earnings and risk.
- [By Logan Wallace]
Fifth Street Asset Management (OTCMKTS: FSAM) and Triangle Capital (NYSE:TCAP) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, risk, profitability, analyst recommendations, valuation, earnings and dividends.
Top 10 Value Stocks For 2019: Unifirst Corporation(UNF)
Advisors' Opinion:- [By Max Byerly]
Dolphin Entertainment (NYSE: UNF) and UniFirst (NYSE:UNF) are both business services companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, valuation, profitability and risk.
- [By Shane Hupp]
UniFirst Corp (NYSE:UNF)’s share price hit a new 52-week high and low on Thursday . The company traded as low as $179.10 and last traded at $177.85, with a volume of 768 shares traded. The stock had previously closed at $178.90.
- [By Motley Fool Staff]
UniFirst (NYSE:UNF) Q3 2018 Earnings Conference CallJun. 27, 2018 9:00 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Max Byerly]
Barrington Research reaffirmed their hold rating on shares of UniFirst (NYSE:UNF) in a research note released on Friday. Barrington Research also issued estimates for UniFirst’s Q4 2018 earnings at $1.62 EPS, FY2018 earnings at $6.44 EPS and FY2019 earnings at $7.31 EPS.
Top 10 Value Stocks For 2019: CSX Corporation(CSX)
Advisors' Opinion:- [By Logan Wallace]
CSX (NASDAQ:CSX) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a note issued to investors on Monday.
- [By Dan Caplinger]
The railroad industry has gone through a lot in recent years, as turbulent conditions in many of the end markets that key railroad customers serve have led to volatile levels of volume and revenue. CSX (NASDAQ:CSX) has also had to deal with an unexpected CEO transition in the middle of turnaround efforts that the railroad company had hoped would be able to pull it out of a long funk.
- [By Asit Sharma]
It also hasn't helped that competitor CSX Corporation (NASDAQ:CSX) just reported a massive year-over-year jump of nearly 6 percentage points in its operating ratio, from 69.4% to 63.7%, in the first quarter of 2018. I recently described how a more aggressive approach to operations appears to be fueling CSX's productivity. And yet it should be acknowledged that CSX isn't facing a congestion event like Union Pacific's.
- [By ]
CSX Corp. (CSX) shares jumped in after-hours trading Tuesday, April 17, after reporting a top- and bottom-line beat for the first quarter, driven by lower costs and restructuring expenses.
- [By Motley Fool Staff]
In this segment from the MarketFoolery podcast, host Chris Hill and Motley Fool Asset Management's Bill Barker take a gander at the results from freight railroad giant CSX (NASDAQ:CSX), which earned almost $700 million in its first quarter -- a huge beat relative to expectations, with bottom-line growth of more than 50% annually.
Top 10 Value Stocks For 2019: Identiv, Inc.(INVE)
Advisors' Opinion:- [By Lisa Levin] Gainers The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance. WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results. MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast. Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39. Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval. Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results. ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings. Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million. Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results. Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results. VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71. Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results. Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results. Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results. Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739. Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
Top 10 Value Stocks For 2019: Moelis & Company(MC)
Advisors' Opinion:- [By Shane Hupp]
Moelis & Co (NYSE: MC) and Monroe Capital (NASDAQ:MRCC) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, risk, institutional ownership, earnings, dividends and analyst recommendations.
- [By Motley Fool Transcribers]
Moelis & Company (NYSE:MC)Q4 2018 Earnings Conference CallFeb. 06, 2019, 5:00 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Max Byerly]
MAN Grp PLC/ADR (NYSE: MC) and Moelis & Co (NYSE:MC) are both mid-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.
No comments:
Post a Comment